Generic Name and Formulations:
Gatifloxacin 0.3%; oph soln; contains benzalkonium chloride.
Indications for ZYMAR:
Susceptible infections of the conjunctiva.
Adults and Children:
<1yr: not established. ≥1yr: 1 drop every 2 hours while awake for 2 days (up to 8 times daily), then 1 drop 4 times daily while awake for 5 more days.
Remove contact lenses. Risk of corneal endothelial cell injury: do not administer into anterior chamber of the eye. Discontinue if superinfection or hypersensitivity occurs. Pregnancy. Nursing mothers.
Conjunctival irritation, increased lacrimation, keratitis, papillary conjunctivitis, chemosis, conjunctival hemorrhage, dry or red eye, eye discharge or pain, eyelid edema, headache, reduced visual acuity, taste disturbance.
Psychiatry Advisor Articles
- Anxiety Prevention Interventions: How Effective Are They?
- ADHD, Comorbid Bipolar Disorder Share Similar Neurocognitive Profiles
- Antidepressant Use and Dementia Risk in the Elderly
- Risk for Adverse Outcomes With Antidepressants in Dementia
- Chronic Alcohol Use Disorder Symptoms Occur Regardless of Social Status
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Physicians Spend Nearly 6 Hours on EHR Tasks Per Day
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Buprenorphine, Methadone Combined With CNS Depressants May Lead to SAEs
- Vagus Nerve Stimulation in HIV-Associated Depression
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- Retirement Saving Behavior Associated With Psychological Distress